Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa

Pembrolizumab is a humanized immunoglobulin G4-kappa anti-PD1 antibody used in the treatment of different solid tumors or haematological malignancies. A liquid chromatography coupled with a high resolution mass spectrometry (orbitrap technology) method was fully developed, optimized, and validated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Millet, Aurélien, Khoudour, Nihel, Guitton, Jérôme, Lebert, Dorothée, Goldwasser, François, Blanchet, Benoit, Machon, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229588/
https://www.ncbi.nlm.nih.gov/pubmed/34070939
http://dx.doi.org/10.3390/biomedicines9060621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229588/
https://www.ncbi.nlm.nih.gov/pubmed/34070939
http://dx.doi.org/10.3390/biomedicines9060621

Ejemplares similares